Deison Technology Park is foundation for how wellness is made here

Conroe is among our nation’s fastest-growing cities and is viewed as a destination of choice, in part, because people recognize the city as an ideal place to make a living. Conroe also appeals to those driven by a desire to balance business with being healthy which is a reason why Wellness is Made Here.

The city’s Deison Technology Park, a 248-acre corporate campus, is tailor-made for the 21st century’s wellness-focused businesses. Constructed in 2013, the Park is a modern, eco-friendly space with available sites ranging from two to 42 acres. Located off FM 1484 and Technology Park Drive in Conroe and just a three-minute drive from Conroe-North Houston Regional Airport, Deison features a direct connection to I-45 and provides ideal space for research and development, technology, life sciences, pharmaceutical, and more.

“Deison Technology Park’s combination of natural beauty, convenient location and practical business environment showcases the very best of Conroe,” offered Conroe Economic Development Council Deputy Director, Laura Lea Palmer. “The Park is the perfect choice for businesses who value wellness for employees and operations.”

The space caters to businesses dually passionate about a healthy bottom line and being healthy in body and mind. Deison Technology Park showcases amenities of an idyllic park setting with a central green space, elevated wooden paths, hiking and biking trails and peaceful gathering areas. With wellness weaved throughout its foundations of business and innovation, it’s fitting the Park’s first occupant is a company dedicated to revolutionizing the biopharmaceutical industry.

VGXI, Inc. (VGXI) is a leader in plasmid DNA contract manufacturing boasting more than 20 years of experience providing high quality products to biomedical researchers worldwide. To support clients that develop DNA vaccines, immunotherapies, cell therapies, and gene therapies, VGXI opened its new headquarters at Conroe’s Deison Technology Park in October 2022.

The company’s 120,000 square-foot, campus-style office and manufacturing site provides state-of-the-art production equipment to help tackle projects of all sizes and serve the global community of next-generation therapeutic developers. The facility features four distinct manufacturing trains including dedicated areas available for mRNA manufacturing and small-scale, rapid turnaround services for personalized therapies. Employees are offered abundant office space, conference and break-out rooms, a library and a training room. 

“VGXI was the ideal fit to be Deison Technology Park’s first tenant. A leader in the biopharmaceutical industry, VGXI showcases how modern, high-tech businesses and their employees can thrive in Deison’s tranquil campus environment that fosters creativity,” added Palmer. “We are seeing serious interest in Deison Technology Park from similar health-science companies.”

Since being founded in 1997, VGXI has been at the forefront in developing DNA vaccines for deadly viruses like Zika, Ebola, MERS and COVID-19. The company was recently accepted as a member of both the US Government’s Rapid Response Partnership Vehicle (RRPV) and the Biopharmaceutical Manufacturing Preparedness (BioMap) Consortium.

Committed to helping businesses and residents foster multidimensional fitness in various aspects of personal and professional lives, Conroe proves Wellness is Made Here.